CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...